Aimax Bhd (XKLS:0041) 1-Year Sharpe Ratio: 1.05 (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aimax Bhd 1-Year Sharpe Ratio?

Aimax Bhd XKLS:0041 +100.00% 1-Year Sharpe Ratio is 1.05 as of Aug. 13, 2026. The stock has 8 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-13), Aimax Bhd's 1-Year Sharpe Ratio is 1.05.

Aimax Bhd  (XKLS:0041) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Aimax Bhd 1-Year Sharpe Ratio Related Terms

XKLS:0041 vs MMM, HON: 1-Year Sharpe Ratio Comparison

For the Conglomerates subindustry, Aimax Bhd's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aimax Bhd 1-Year Sharpe Ratio vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Aimax Bhd's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Aimax Bhd's 1-Year Sharpe Ratio falls into.


Aimax Bhd 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 1.05 mean?
Aimax Bhd (XKLS:0041) has a 1-Year Sharpe Ratio of 1.05 as of Aug. 13, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Aimax Bhd and its competitors.
Is Aimax Bhd's 1-Year Sharpe Ratio too high?
Aimax Bhd's current 1-Year Sharpe Ratio is 1.05.
How does Aimax Bhd's 1-Year Sharpe Ratio compare to MMM and HON?
Aimax Bhd's 1-Year Sharpe Ratio of 1.05 can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Conglomerates company?
A good 1-Year Sharpe Ratio depends on the Conglomerates industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Aimax Bhd and its competitors. Aimax Bhd's current 1-Year Sharpe Ratio is 1.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aimax Bhd stock overvalued right now?
Based on GuruFocus' analysis, Aimax Bhd (XKLS:0041) is currently considered Fairly Valued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.01 — trading right at its estimated fair value. The current 1-Year Sharpe Ratio is 1.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Aimax Bhd (XKLS:0041), the current 1-Year Sharpe Ratio is 1.05 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aimax Bhd Business Description

Address C-01-3, Block C Plaza Glomac, No 6, Jalan SS7/19, Kelana Jaya, Petaling Jaya, SGR, MYS, 47301
Aimax Bhd, formerly known as Hong Seng Consolidated Bhd, is operating as an investment holding company. The company operates in four operating segments. The healthcare segment consists of a medical diagnostic and research laboratory and wholesale of pharmaceutical and medical goods; the Financial services include Moneylending; the Gloves segment consists of Manufacturing and trading of rubber gloves; and Seafood segment which consists of Trading of Seafood products. The majority of the revenue is derived from the healthcare segment.